Diagnosis: Acute ischemic stroke caused by distal left internal carotid artery occlusion, with salvageable penumbral tissue and a persistent large-vessel occlusion. B.H. Buck is a Fellow of the ...

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Intensive BP lowering after successful endovascular thrombectomy for acute anterior circulation ischemic stroke did not improve 90-day functional outcomes vs. standard BP control, a speaker ...

The medical institution initially earned the certification in 2022, and is required to recertify annually. Pullman Regional ...

He continued, “The improved time to imaging compared to conventional MRI could facilitate quicker decision-making in acute stroke management, which could lead to the implementation of more ...